The Global Strategy for. Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2023 report). https://goldcopd.org/2023-gold-report-2/ (assessed November 2022).
Celli B, Fabbri L, Criner G, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med 2022;206(11):1317–1325. DOI: 10.1164/rccm.202204-0671PP
Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a lancet commission. Lancet 2022;400(10356):921–972. DOI: 10.1016/S0140-6736(22)01273-9
Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med 2022;10(5):447–458. DOI: 10.1016/S2213-2600(21)00511-7
World Health Organization. Projections of mortality and causes of death, 2016 and 2060, online information available here: https://colinmathers.com/2022/05/10/projections-of-global-deaths-from-2016-to-2060/ [accessed October 2022].
Agusti A, Melen E, DeMeo DL, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med 2022;10(5):512–524. DOI: 10.1016/S2213-2600(21)00555-5
Han MK, Agusti A, Celli BR, et al. From GOLD 0 to pre-COPD. Am J Respir Crit Care Med 2021;203(4):414–423. DOI: 10.1164/rccm.202008-3328PP
Pandey AK, Verma AK, Kant S, et al. The relationship between clinical phenotypes and gold groups/stages in patients with chronic obstructive pulmonary disease. Cureus 2022;14(12):e32116. DOI: 10.7759/cureus.32116
Mitchell JP, Nagel MW. Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. Prim Care Respir J 2007;16(4): 207–214. DOI: 10.3132/pcrj.2007.00034
de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume ct screening in a randomized trial. N Engl J Med 2020;382(6):503–513. DOI: 10.1056/NEJMoa1911793
Celli BR, Fabbri LM, Aaron SD, et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal. Am J Respir Crit Care Med 2021;204(11):1251–1258. DOI: 10.1164/rccm.202108-1819PP
Pandey AK, Singh S, Verma AK, et al. Management strategies of COPD during the COVID-19 pandemic. TANAFFOS (Respiration) RSPR-2205-1217(Accepted).
